Combination therapies for B-cell lymphomas comprising administration of anti-CD20 antibodies | Patent Number 09296821

US 09296821 B2
Application Number13524896
Publication NumberUS 20120258102 A1
Pendency3 years, 9 months, 18 days
Filled DateJun 15, 2012
Priority DateAug 11, 1998
Publication DateOct 11, 2012
Expiration DateMar 29, 2020
Inventor/ApplicantsAntonio J. Grillo-López
ExaminesSCHWADRON, RONALD B
Art Unit1644
Technology Center1600
Law Firm
You must be logged in to view
Login
Attorneys
Subscription-Only
View Concierge Program
Patent Prosecution report image

Empower your practice with Patexia Publication Prosecution IP Module.

Get access to our exclusive rankings and unlock powerful data.

Looking for a Publication Attorney?

Get in touch with our team or create your account to start exploring a network of over 120K attorneys.